Gursel Aktan

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

Lajos Pusztai, Rita Nanda, L. Pusztai, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

Eileen Holmes, Patrick Flamen, Camilo Garcia, 2013, The Journal of Nuclear Medicine.

LBA13Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086

Peter Schmid, Rita Nanda, Sherene Loi, 2017 .